Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAR trial of acetazolamide for cystoid macular edema in inherited retinal dystrophies
NL-OMON51635Phase 2Completed
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of acetazolamide in cystoid macular edema (CME) and Fundus dystrophy (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Effective dosage determination, Treatment outcome and 1 more. Started Jan 2023; status: completed.
02
Drugs
acetazolamide
03
Conditions
cystoid macular edema (CME)Fundus dystrophy
Beyond the preview
Go deeper on NL-OMON51635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51635.